Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Tenet Healthcare (THC) PT Raised to $170 at Mizuho
July 26, 2024 1:55 PM EDTMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
July 25, 2024 5:06 AM EDTDeutsche Bank analyst Pito Chickering raised the price target on Tenet Healthcare (NYSE: THC) to $160.00 (from $155.00) while maintaining a Buy rating.
The analyst comments "Updated 2024 guidance of $3.9b EBITDA for 2024 and $3.975b at the high end is within spitting distance of consensus... More
Tenet Healthcare (THC) PT Raised to $171 at Citi
July 24, 2024 4:47 PM EDTCiti analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.
The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More
